The Immunotherapy Drugs Market was valued at USD 246.00 billion in 2023 and is projected to reach USD 829.78 billion by 2032, expanding at a CAGR of 14.49% during the forecast period of 2024-2032. This remarkable growth is fueled by rising cancer prevalence, rapid advancements in immunotherapy research, and increasing approvals of monoclonal antibodies,...

During the forecast period, the size of the worldwide olfactory neuroblastoma market is anticipated to expand steadily in terms of revenue CAGR. The market is expanding as a result of a number of key factors, including the increased incidence of cancer and the number of clinical trials and research for the treatment of olfactory neuroblastoma. Additionally, the industry's revenue growth is...